tiprankstipranks
Trending News
More News >
co.don AG (DE:CNW)
FRANKFURT:CNW

co.don AG (CNW) Price & Analysis

Compare
1 Followers

CNW Stock Chart & Stats

€0.01
€0.00(0.00%)
At close: 4:00 PM EDT
€0.01
€0.00(0.00%)

CNW FAQ

What was co.don AG’s price range in the past 12 months?
co.don AG lowest stock price was €0.01 and its highest was €0.04 in the past 12 months.
    What is co.don AG’s market cap?
    co.don AG’s market cap is €280.60K.
      When is co.don AG’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were co.don AG’s earnings last quarter?
      Currently, no data Available
      Is co.don AG overvalued?
      According to Wall Street analysts co.don AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does co.don AG pay dividends?
        co.don AG does not currently pay dividends.
        What is co.don AG’s EPS estimate?
        co.don AG’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does co.don AG have?
        co.don AG has 26,723,358 shares outstanding.
          What happened to co.don AG’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of co.don AG?
          Currently, no hedge funds are holding shares in DE:CNW
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            co.don AG

            Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.
            Similar Stocks
            Company
            Price & Change
            Follow
            4SC AG
            B.R.A.I.N. Biotechnology Research and Information Network
            Epigenomics
            Heidelberg Pharma AG
            CytoTools AG
            Popular Stocks